NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 348 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $109,000 | -91.6% | 20,156 | -69.1% | 0.00% | -100.0% |
| Q1 2021 | $1,303,000 | -35.7% | 65,154 | -45.3% | 0.01% | -33.3% |
| Q4 2020 | $2,025,000 | +1.2% | 119,149 | -1.2% | 0.01% | +12.5% |
| Q3 2020 | $2,001,000 | -41.5% | 120,603 | -18.4% | 0.01% | -52.9% |
| Q2 2020 | $3,423,000 | +173.0% | 147,814 | +154.4% | 0.02% | +325.0% |
| Q4 2019 | $1,254,000 | -65.4% | 58,097 | -70.8% | 0.00% | -69.2% |
| Q3 2019 | $3,624,000 | -2.4% | 198,960 | +90.6% | 0.01% | 0.0% |
| Q2 2019 | $3,715,000 | +624.2% | 104,406 | +583.8% | 0.01% | +550.0% |
| Q1 2019 | $513,000 | -40.1% | 15,268 | -41.5% | 0.00% | -50.0% |
| Q4 2018 | $857,000 | -93.4% | 26,081 | -87.8% | 0.00% | -91.5% |
| Q3 2018 | $12,997,000 | +948.1% | 213,203 | +739.5% | 0.05% | +840.0% |
| Q2 2018 | $1,240,000 | -63.5% | 25,396 | -20.6% | 0.01% | -68.8% |
| Q1 2018 | $3,400,000 | – | 32,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |